Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies
- 4 July 2003
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 146 (1), 33-41
- https://doi.org/10.1016/s0002-8703(03)00121-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Percutaneous Coronary Intervention After Subcutaneous Enoxaparin Pretreatment in Patients With Unstable Angina PectorisCirculation, 2001
- Antithrombotic Agents in Coronary Artery DiseaseChest, 2001
- Effects of various anticoagulant treatments on von Willebrand factor release in unstable anginaJournal of the American College of Cardiology, 2000
- Assessment of the Treatment Effect of Enoxaparin for Unstable Angina/Non–Q-Wave Myocardial InfarctionCirculation, 1999
- Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial InfarctionCirculation, 1999
- Early Increase of von Willebrand Factor Predicts Adverse Outcome in Unstable Coronary Artery DiseaseCirculation, 1998
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery DiseaseNew England Journal of Medicine, 1997
- Individual risk assessment for intracranial haemorrhage during thrombolytic therapyThe Lancet, 1993
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976